Literature DB >> 26253708

Bioimpedance Analysis as a Method to Evaluate the Proportion of Fatty and Muscle Tissues in Progressive Myopathy in Pompe Disease.

Agnieszka Różdżyńska-Świątkowska1, Elżbieta Jurkiewicz2, Anna Tylki-Szymańska3.   

Abstract

During progressive myopathy, the space of atrophic muscle tissue is gradually filled by fatty tissue. The proportion of these two tissue types relative to body mass provides an indication of the extent of muscle tissue destruction, i.e., the progression and severity of the disease.In this study we use Pompe disease as an example to report the new possibility of using bioimpedance analysis (BIA) to assess the relative proportion of fatty and muscle tissue in diseases associated with muscle atrophy, thus enabling the assessment of disease progression and the effectiveness of treatment. Results from BIA analysis were compared with magnetic resonance images.The results of muscle magnetic resonance images and BIA analysis were similar, which suggests that BIA may provide valuable diagnostic guidance for the assessment of the progression of the disorder.

Entities:  

Keywords:  Bioimpedance analysis (BIA); Muscle atrophy; Myopathies; Pompe disease

Year:  2015        PMID: 26253708      PMCID: PMC4864712          DOI: 10.1007/8904_2015_473

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  21 in total

1.  Relation between body composition and age in healthy Japanese subjects.

Authors:  H Ito; A Ohshima; N Ohto; M Ogasawara; M Tsuzuki; K Takao; C Hijii; H Tanaka; K Nishioka
Journal:  Eur J Clin Nutr       Date:  2001-06       Impact factor: 4.016

2.  Muscle MRI in adult-onset acid maltase deficiency.

Authors:  Anna Pichiecchio; Carla Uggetti; Sabrina Ravaglia; Maria Grazia Egitto; Miriam Rossi; Giorgio Sandrini; Cesare Danesino
Journal:  Neuromuscul Disord       Date:  2004-01       Impact factor: 4.296

3.  Therapeutic advances in the management of Pompe disease and other metabolic myopathies.

Authors:  Corrado Angelini; Anna Chiara Nascimbeni; Claudio Semplicini
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

4.  New bioimpedance model accurately predicts lower limb muscle volume: validation by magnetic resonance imaging.

Authors:  S Salinari; A Bertuzzi; G Mingrone; E Capristo; A Pietrobelli; P Campioni; A V Greco; S B Heymsfield
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-04       Impact factor: 4.310

5.  Muscle computed tomography in adult-onset acid maltase deficiency.

Authors:  A E de Jager; T M van der Vliet; T C van der Ree; B J Oosterink; M C Loonen
Journal:  Muscle Nerve       Date:  1998-03       Impact factor: 3.217

6.  Adult onset glycogen storage disease type II (adult onset Pompe disease): report and magnetic resonance images of two cases.

Authors:  Andrew Del Gaizo; Sima Banerjee; Michael Terk
Journal:  Skeletal Radiol       Date:  2009-12       Impact factor: 2.199

7.  Comparison of segmental with whole-body impedance measurements in peritoneal dialysis patients.

Authors:  Lexa Nescolarde; Teresa Doñate; Antonio Piccoli; Javier Rosell
Journal:  Med Eng Phys       Date:  2007-10-30       Impact factor: 2.242

8.  Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.

Authors:  Michele Gaeta; Emanuele Barca; Paolo Ruggeri; Fabio Minutoli; Carmelo Rodolico; Silvio Mazziotti; Demetrio Milardi; Olimpia Musumeci; Antonio Toscano
Journal:  Mol Genet Metab       Date:  2013-07-09       Impact factor: 4.797

9.  Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry.

Authors:  S B Heymsfield; R Smith; M Aulet; B Bensen; S Lichtman; J Wang; R N Pierson
Journal:  Am J Clin Nutr       Date:  1990-08       Impact factor: 7.045

Review 10.  Neuromuscular imaging in inherited muscle diseases.

Authors:  Mike P Wattjes; Rudolf A Kley; Dirk Fischer
Journal:  Eur Radiol       Date:  2010-04-27       Impact factor: 5.315

View more
  3 in total

1.  Quantitative muscle ultrasound and electrical impedance myography in late onset Pompe disease: A pilot study of reliability, longitudinal change and correlation with function.

Authors:  Lisa D Hobson-Webb; Paul J Zwelling; Shruti S Raja; Ashley N Pifer; Priya S Kishnani
Journal:  Mol Genet Metab Rep       Date:  2021-07-30

2.  Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.

Authors:  J Blauensteiner; R Bertinat; L E León; M Riederer; N Sepúlveda; F Westermeier
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

3.  2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease.

Authors:  U Plöckinger; V Prasad; A Ziagaki; N Tiling; A Poellinger
Journal:  Hum Genomics       Date:  2018-03-09       Impact factor: 4.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.